Similar articles

• Coronary artery disease in Saudi Arabia.

  Al-Nozha MM, Arafah MR, Al-Mazrou YY, Al-Maatouq MA, Khan NB, Khalil MZ, Al-Khadra AH, Al-Marzouki K, Abdullah MA, Al-Harthi SS, Al-Shahid MS, Nouh MS, Al-Mobeireek A. Al-Nozha MM, et al. Saudi Med J. 2004 Sep;25(9):1165-71. Saudi Med J. 2004. PMID: 15448760
• Risk factors for coronary heart disease in Indians: a case-control study from Eastern India.

  Guha S, Ghosh A, Chatterjee N, Pal S, Guha S, Chatterjee S, Deb PK, Dawn B. Guha S, et al. Indian Heart J. 2005 Nov-Dec;57(6):738-40. Indian Heart J. 2005. PMID: 16521652
• Hyperhomocysteinemia, coronary heart disease, and diabetes mellitus as predicted by various definitions for metabolic syndrome in a hypertensive Saudi population.

  Al-Daghri NM. Al-Daghri NM. Saudi Med J. 2007 Mar;28(3):339-46. Saudi Med J. 2007. PMID: 17334456
• Diabetic dyslipidemia and the heart.

  Vasudevan AR, Garber AJ. Vasudevan AR, et al. Heart Fail Clin. 2006 Jan;2(1):37-52. doi: 10.1016/j.hfc.2005.12.001. Heart Fail Clin. 2006. PMID: 17386875 Review. No abstract available.
• Prognostic significance of silent coronary artery disease in type 2 diabetes.

  Zellweger MJ. Zellweger MJ. Herz. 2006 May;31(3):240-5. doi: 10.1007/s00059-006-2790-1. Herz. 2006. PMID: 16770561 Review.